Muscle Pharm Corporation (MSLPQ)

[BenF]

EXTREME DILUTION MSLP STOCK AND HIGH ADMINISTRATIVE EXPENSES

Have any of you done more research on the impact of all these potential dilutions. If so, please reply back and justify why this stock could trade more than 2 cents?

Also looking at the financial results for latest quarter, this company's sales is 5.7 Mil , cost of sales is 3.8 Mil, but administrative expenses are 4.3 Mil. So Loss from Operations is actually WIDENING, suddenly this quarter interest expenses and derivative expenses have become positive instead of negative (How so? Is this a finance company lending money?) Take a look at the SEC filing below:

http://sec.gov/Archives/edgar/data/1415684/000114420411064430/v240359_10q.htm

During the nine months ended September 30, 2011, the Company issued $3,798,733 in convertible debt – secured – derivative liabilities. The Company issued these debt instruments with 13 different sets of conversion terms. The Material terms of the Company’s convertible debt – secured – derivative liabilities are as follows:


Amount of Principal Raised

Interest Rate
6% - 12 %
Default interest rate
15% - 22 %
Maturity

April 5, 2011 to June 2, 2014

Conversion terms 1

Average 10 day trade pricing divided by 200% of outstanding principal balance
$ 827,600
Conversion terms 2

Lesser of: Average of the lowest 2 closing prices of the 5 days preceding conversion date or $0.025/share
$ 775,000
Conversion terms 3

60% of the average of the lowest 3 closing prices in the 10 days preceding conversion date
$ 170,000
Conversion terms 4
$0.03 $ 100,000
Conversion terms 5

65% of the average of the lowest 3 closing prices in the 30 days preceding conversion
$ 303,800
Conversion terms 6

62% of the lowest closing prices in the 7 days preceding conversion date
$ 40,000
Conversion terms 7

70% of the average of the lowest 3 closing prices in the 30 days preceding conversion
$ 600,000
Conversion terms 8

50% of the average closing prices in the 10 days preceding conversion
$ 85,000
Conversion terms 9

45% of the lowest 3 closing prices in the 10 days preceding conversion
$ 277,500
Conversion terms 10

35% of the lowest 3 closing prices in the 10 days preceding conversion
$ 100,000
Conversion terms 11

Lesser of: 50% of average of the lowest 3 closing prices of the 20 days preceding conversion date or $0.05/share
$ 33,000
Conversion terms 12

50% of lowest trade price in preceding 20 days
$ 45,000
Conversion terms 13

80% of lowest trade price in preceding 30 days
$ 441,833
$ 3,798,733

During the nine months ended September 30, 2011, the Company converted $2,379,913 in notes into 132,321,172 shares of the Company’s common stock at prices ranging from $0.01 to $0.08 per share, based upon the terms of the debt conversion.